The Musculoskeletal Tumor Registry (MsTR) is part of the AAOS Registry Program. As of April 2024, the MsTR has gathered data from more than 1,500 procedures related to bone and soft tissue sarcomas across various regions of the body.
MsTR Participation Benefits
Participation in the MsTR helps clinicians and health systems track function, complications, and outcomes in patients treated for sarcomas with the potential to expand to metastatic bone disease.
Learn About Quality Collaborations
Registry data can help meet a participating site’s requirements for collaborative programs like quality certifications and federal quality initiatives.
Data in Practice
Discover how registry data transforms orthopaedic practice with real-life results—click to explore MsTR case scenarios and the transformative impact of data-driven healthcare.
Data Submission
Participating sites may submit data utilizing an AAOS Registry Program Authorized Vendor. While MsTR is electronic health record agnostic, Epic SmartForms are available that allow surgeons to input exclusive data concerning their sarcoma patients at the point of care. The SmartForms help enahnce and standardize the data within the Registry by collecting data that cannot be extracted from the EHR automatically. Visit the data submission page for details on elements collected, Epic SmartForms, and support resources.
Registry Enhancements
Learn about recent updates to the RegistryInsights platform and new opportunities to engage with AAOS Registry data.